| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/2010 | CA2155303C Treatment for insulin dependent diabetes |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/15/2010 | WO2010042932A1 High caloric enteral formulations |
| 04/15/2010 | WO2010042868A2 Methods for treating obesity |
| 04/15/2010 | WO2010042821A1 Method of treating necrotizing enterocolitis using heparin binding epidermal growth factor |
| 04/15/2010 | WO2010042799A2 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 04/15/2010 | WO2010042796A1 Compounds for treatment of alzheimer's disease |
| 04/15/2010 | WO2010042755A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042751A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042749A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042747A2 Fgf21 mutants and uses thereof |
| 04/15/2010 | WO2010042743A2 Chimeric multiplexes, compositions, and methods for using same |
| 04/15/2010 | WO2010042742A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042697A1 Regulation of lymphocytes and uses therefor |
| 04/15/2010 | WO2010042691A1 Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl) |
| 04/15/2010 | WO2010042640A1 Use of anti-il-20 antibody for treating stroke |
| 04/15/2010 | WO2010042548A2 Methods of treating inflammation |
| 04/15/2010 | WO2010042534A1 Peptides and methods of use |
| 04/15/2010 | WO2010042356A1 Cgrp receptor antagonists |
| 04/15/2010 | WO2010042225A2 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 04/15/2010 | WO2010042203A1 Dosage forms that facilitate rapid activation of zymogen |
| 04/15/2010 | WO2010042202A1 Methods for treatment of podocyte injury |
| 04/15/2010 | WO2010041963A1 Treating or preventing gout |
| 04/15/2010 | WO2010041913A2 Novel uses of grs proteins or fragments thereof |
| 04/15/2010 | WO2010041889A2 Pharmaceutical composition for preventing or treating chronic obstructive pulmonary disease |
| 04/15/2010 | WO2010041827A2 NF-κB INHIBITOR CONTAINING ARH1 PROTEIN OR GENE ENCODING THE SAME |
| 04/15/2010 | WO2010041716A1 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue |
| 04/15/2010 | WO2010041699A1 Btma2 compound |
| 04/15/2010 | WO2010041636A1 Tissue plug |
| 04/15/2010 | WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 |
| 04/15/2010 | WO2010041400A1 Biofilm formation inhibitor |
| 04/15/2010 | WO2010041241A2 Hiv-1 integrase derived peptides and compositions |
| 04/15/2010 | WO2010041150A2 Pharmaceutical peptides for the treatment of inflammatory diseases |
| 04/15/2010 | WO2010041140A2 Treatment of proliferative disorders with a death receptor agonist |
| 04/15/2010 | WO2010041138A2 Complex between human insulin and an amphiphilic polymer, and use of said complex for preparing a quick human insulin formulation |
| 04/15/2010 | WO2010041096A1 Orally administrable immunostimulant product for aquaculture |
| 04/15/2010 | WO2010040998A1 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 04/15/2010 | WO2010040901A1 Alternative oxidase and uses thereof |
| 04/15/2010 | WO2010040882A1 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
| 04/15/2010 | WO2010040845A1 Polypeptides having antimicrobial activity |
| 04/15/2010 | WO2010040830A1 Multiple n-methylated cyclic hexapeptides for treatment of neurogenic inflammation |
| 04/15/2010 | WO2010040803A2 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia |
| 04/15/2010 | WO2010040769A1 PRODUCTION AND USE OF HIGH-PURITY HEMOPARATIDE (hPTH-1-37) FOR THE TREATMENT OF INFLAMMATORY SCALING SKIN DISEASES |
| 04/15/2010 | WO2010040362A1 Antibodies against rns-induced modified cytokines and uses thereof |
| 04/15/2010 | WO2010040305A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 04/15/2010 | WO2010040204A1 Detection of granulosa-cell tumors |
| 04/15/2010 | WO2010022213A3 Compositions and methods for preserving pancreatic islet mass |
| 04/15/2010 | WO2010022198A3 Rcc t cell receptors and related materials and methods of use |
| 04/15/2010 | WO2010017332A3 Radioprotectants targeting thrombospondin-1 and cd47 |
| 04/15/2010 | WO2010016938A3 Glucose-dependent insulinotropic polypeptide analogues |
| 04/15/2010 | WO2010014888A3 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 04/15/2010 | WO2010011735A3 Modified bovine g-csf polypeptides and their uses |
| 04/15/2010 | WO2010006343A3 Glycopeptide constructs and uses thereof |
| 04/15/2010 | WO2010004052A3 Agonists of nr2f6 for immunosuppression |
| 04/15/2010 | WO2010003668A3 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 04/15/2010 | WO2009151907A3 Compositions and methods for using cells to treat heart tissue |
| 04/15/2010 | WO2009150040A3 Opiorphin for use as a psychostimulant agent |
| 04/15/2010 | WO2009137436A3 Peptide conjugates |
| 04/15/2010 | WO2009134420A3 Epigenetic silencing of tumor suppressor genes |
| 04/15/2010 | WO2009134396A3 Use of corticotropin-releasing factor for the treatment of cancer |
| 04/15/2010 | WO2009111649A3 Methods and compositions for delivery of exogenous factors to nervous system sites |
| 04/15/2010 | WO2009106767A3 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 04/15/2010 | WO2009104001A3 Oligopeptidic compounds and uses thereof |
| 04/15/2010 | WO2009080299A8 Sm-protein based secretion engineering |
| 04/15/2010 | WO2009061411A3 Use melanocortins to treat insulin sensitivity |
| 04/15/2010 | WO2009006246A8 Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome |
| 04/15/2010 | WO2005074981A8 Inhibitors of tgf-r signaling for treatment of cns disorders |
| 04/15/2010 | US20100095408 Anti-Pathogen Systems |
| 04/15/2010 | US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100095387 Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases |
| 04/15/2010 | US20100093987 Inhibitor Nucleic Acids |
| 04/15/2010 | US20100093978 Dkk-related proteins |
| 04/15/2010 | US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 04/15/2010 | US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 04/15/2010 | US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| 04/15/2010 | US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |
| 04/15/2010 | US20100093838 Regulation of angiogenesis with zinc finger proteins |
| 04/15/2010 | US20100093837 Microrna molecules |
| 04/15/2010 | US20100093834 Manipulation of neuronal ion channels |
| 04/15/2010 | US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 04/15/2010 | US20100093829 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 04/15/2010 | US20100093791 Therapeutic Compositions |
| 04/15/2010 | US20100093646 Method for enhancing memory in normal individual |
| 04/15/2010 | US20100093645 SMAC Peptidomimetics and the Uses Thereof |
| 04/15/2010 | US20100093644 Template-fixed peptidomimetics |
| 04/15/2010 | US20100093643 Cardioprotective compounds |
| 04/15/2010 | US20100093642 Novel polypeptides |
| 04/15/2010 | US20100093641 Silk protein-mimicking peptides and compositions for preventing or treating cranial neuropathies comprising the same |
| 04/15/2010 | US20100093640 Ace-inhibitory peptides from whey and methods for providing the same |
| 04/15/2010 | US20100093639 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| 04/15/2010 | US20100093638 Treament for chemical substance addiction |
| 04/15/2010 | US20100093636 Methods of treating inflammation |
| 04/15/2010 | US20100093635 Agonists of Guanylate Cyclase UseFul For The Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 04/15/2010 | US20100093634 Methods for regulating urinary potassium |
| 04/15/2010 | US20100093633 Polypeptides having antimicrobial activity |
| 04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 04/15/2010 | US20100093631 Method of treating cravings by administration of nerve growth factor |
| 04/15/2010 | US20100093630 Mammalian chemokines; related reagents |
| 04/15/2010 | US20100093629 Genes and polypeptides relating to human pancreatic cancers |